Skip to main content

EvolveImmune Therapeutics

Branford, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

$20.0M raised
Oct 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EvolveImmune Therapeutics

How much funding has EvolveImmune Therapeutics raised?
EvolveImmune Therapeutics has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
Who are EvolveImmune Therapeutics's investors?
EvolveImmune Therapeutics's investors include Pfizer, Elm Street Ventures, Yonjin Venture, Takeda Ventures, Solasta Ventures.
Where is EvolveImmune Therapeutics headquartered?
EvolveImmune Therapeutics is headquartered in Branford, United States.
What does EvolveImmune Therapeutics do?
EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.
What stage is EvolveImmune Therapeutics at?
EvolveImmune Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"EvolveImmune Therapeutics — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/evolveimmune-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). EvolveImmune Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/evolveimmune-therapeutics
Wikipedia (cite web)
{{cite web |title=EvolveImmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/evolveimmune-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .